The University of California, San Diego is ranked the 9th best public university in the nation, according to U.S. News & World Report’s 2016 Best Colleges guidebook, which was released today. In addition, UC San Diego is named the 39th best university in the U.S. among more than 200 public, private and for-profit institutions.
Two University of California, San Diego-sponsored events in September, over two consecutive Saturdays, highlight the importance of a comprehensive approach to brain research. First, on Sept. 12, is an education and advocacy forum for the public bringing together those affected by Alzheimer's disease, Parkinson's disease, brain injury, stroke, epilepsy, autism, mental illness or depression. Then on Sept. 19 a research symposium will connect local “neurotechnology” innovators to one another and to the region’s business community.
Using “mini-brains” built with induced pluripotent stem cells derived from patients with a rare, but devastating, neurological disorder, researchers at University of California, San Diego School of Medicine say they have identified a drug candidate that appears to “rescue” dysfunctional cells by suppressing a critical genetic alteration.
Sosinsky, a highly regarded scientist and teacher who performed seminal work in the molecular structure of gap junctions and other cell-cell junctions, died yesterday from complications related to a bone marrow transplant. She was 60.
Researchers at University of California, San Diego School of Medicine have documented the accuracy of three new tests for more rapidly diagnosing drug-resistant forms of tuberculosis (TB), which are much harder and more expensive to treat and which, experts say, represent a major threat to global public health.